3D Medicine Corporation

CANNANDA

Non-prescription pharmaceuticals for general health and well-being, pain relief, and the treatment of arthritis; non-prescription pharmaceuticals for the treatment of inflammatory diseases, nutritional supplements for animal foodstuffs; Non-prescription pharmaceuticals for pain relief; non-prescription pain relief pharmaceutical preparations; non-prescription pharmaceuticals for veterinary purposes for general health and well-being, pain relief, the treatment of arthritis, inflammatory diseases, allergies, autoimmune diseases, degenerative nerve diseases and disorders, headaches, and migraines; non-prescription pharmaceutical preparations for the treatment of allergies; non-prescription pharmaceutical preparations for the treatment of autoimmune diseases; non-prescription pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; non-prescription pharmaceutical preparations for the treatment of headaches; non-prescription pharmaceutical preparations for the treatment of migraine; nonprescription pharmaceutical preparations that target and support the endocannabinoid system; all of the aforementioned goods either containing no cannabis or containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol [THC] concentration of not more than 0.3 percent on a dry weight basis and no CBD;

CANNANDA CB2

Non-prescription pharmaceuticals for general health and well-being, pain relief, and the treatment of arthritis; non-prescription pharmaceuticals for the treatment of inflammatory diseases, nutritional supplements for animal foodstuffs; Non-prescription pharmaceuticals for pain relief; pain relief pharmaceutical preparations; non-prescription pharmaceuticals for veterinary purposes for general health and well-being, pain relief, the treatment of arthritis, inflammatory diseases, allergies, autoimmune diseases, degenerative nerve diseases and disorders, headaches, and migraines; non-prescription pharmaceutical preparations for the treatment of allergies; non-prescription pharmaceutical preparations for the treatment of autoimmune diseases; non-prescription pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; non-prescription pharmaceutical preparations for the treatment of headaches; non-prescription pharmaceutical preparations for the treatment of migraine; non-prescription pharmaceutical preparations that target and support the endocannabinoid system; all of the aforementioned goods either containing no cannabis or containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol [THC] concentration of not more than 0.3 percent on a dry weight basis and no CBD;CANNANDA CB TWO;CB2;

CB2

The mark consists of two letters, CB and a number, 2.;pharmaceuticals; pharmaceutical compositions; pharmaceutical preparations; pharmaceutical preparations that target and support the endocannabinoid system;CB TWO;